ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,131.70
1.33%
US Tech 100
17,440.39
2.13%
다우존스 지수
38,699.87
1.24%
Bitcoin
61,813.44
4.55%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Ocular Therapeutix Inc (OCUL)

  7. Ocular Therapeutix Inc (OCUL) 뉴스

OCUL Ocular Therapeutix Inc

6.255
0.385 (6.56%)
최종 업데이트: 03:35:09
15분 지연
기업명 주식 심볼 시장 주식 타입
Ocular Therapeutix Inc OCUL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.385 6.56% 6.255 03:35:09
개장가 저가 고가 종가 전일 종가
6.06 6.03 6.395 5.87
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202420:30GLOBEOcular Therapeutix™ To Present at Two Ophthalmology..
01/05/202420:30GLOBEOcular Therapeutix™ to Host Investor Day in New York City on..
12/03/202405:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/03/202405:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/03/202405:10EDGAR2Form 8-K - Current report
11/03/202419:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
28/02/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202410:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202410:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202410:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/02/202410:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/02/202422:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/02/202421:34EDGAR2Form 8-K - Current report
19/02/202423:00PRNUSAffaMed Therapeutics Announces New Drug Application..
15/02/202422:00GLOBEOcular Therapeutix™ Appoints Steve Meyers to Chief..
15/02/202409:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202421:37GLOBEOcular Therapeutix™ Announces First Subjects Screened in..
07/02/202408:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202408:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202408:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202408:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:41EDGAR2Form 144 - Report of proposed sale of securities
06/02/202406:39EDGAR2Form 144 - Report of proposed sale of securities
06/02/202406:36EDGAR2Form 144 - Report of proposed sale of securities
06/02/202406:33EDGAR2Form 144 - Report of proposed sale of securities
06/02/202406:30EDGAR2Form 144 - Report of proposed sale of securities
03/02/202409:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202409:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202407:41EDGAR2Form 144 - Report of proposed sale of securities
01/02/202407:39EDGAR2Form 144 - Report of proposed sale of securities
01/02/202407:36EDGAR2Form 144 - Report of proposed sale of securities
01/02/202407:34EDGAR2Form 144 - Report of proposed sale of securities
01/02/202407:31EDGAR2Form 144 - Report of proposed sale of securities
25/01/202422:04EDGAR2Form 8-K - Current report
29/12/202306:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
23/12/202306:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/12/202306:52EDGAR2Form SC 13D/A - General statement of acquisition of..
19/12/202306:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:01GLOBEOcular Therapeutix™ Announces Closing of Public Offering of..
15/12/202306:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202322:46EDGAR2Form 8-K - Current report
14/12/202312:09GLOBEOcular Therapeutix™ Announces Pricing of Public Offering of..
14/12/202309:07DJNStocks to Watch: Adobe, Amtech Systems, Ocular Therapeutix
14/12/202306:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202306:01GLOBEOcular Therapeutix™ Announces Proposed Public Offering of..
17/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness

최근 히스토리

NASDAQ
OCUL
Ocular Therapeutix
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유